In today’s recent session, 8.54 million shares of the Pfizer Inc. (NYSE:PFE) have been traded, and its beta is 0.67. Most recently the company’s share price was $28.13, and it changed around -$0.23 or -0.81% from the last close, which brings the market valuation of the company to $159.40B. PFE at last check was trading at a discount to its 52-week high of $37.80, offering almost -34.38% off that amount. The share price’s 52-week low was $25.20, which indicates that the recent value has risen by an impressive 10.42% since then. We note from Pfizer Inc.’s average daily trading volume that its 3-month average coming to 38.47 million.
Pfizer Inc. stock received a consensus recommendation rating of Buy, based on a mean score of 2.31. If we narrow it down even further, the data shows that 0 out of 22 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 9 recommended PFE as a Hold, whereas 11 deemed it a Buy, and 1 rated it as Underweight. Pfizer Inc. is expected to report earnings per share of 0.45 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Pfizer Inc. (NYSE:PFE) trade information
Instantly PFE has been showing red trend so far today with a performance of -0.81% on intraday trading today. The performance over the last five days has remained in the green territory. The company’s shares are currently down -2.29% year-to-date, but still up 4.26% over the last five days. On the other hand, Pfizer Inc. (NYSE:PFE) is -1.95% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $55.44, which translates to bulls needing to increase their stock price by 49.26% from its current value. Analyst projections state that PFE is forecast to be at a low of $20 and a high of $141.39.
Pfizer Inc. (PFE) estimates and forecasts
Pfizer Inc. share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -0.64 percent over the past six months and at a 29.35% annual growth rate that is well above the industry average of -0.30%. The year-over-year growth rate is expected to be 3.60%, up from the previous year.
Consensus estimates provided by 14 financial analysts predict the company will bring in an average of 13.04B in revenue for the current quarter. 13 analysts expect Pfizer Inc. to make 14.8B in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 12.73B and 13.23B respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 2.40%. Forecasts for the next quarter put sales growth at 11.90%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -27.43%. Pfizer Inc. earnings are expected to increase by 27.62% in 2024, but the outlook is positive 14.03% per year for the next five years.
PFE Dividends
Pfizer Inc.’s next quarterly earnings report is expected to be released in July. The annual dividend yield of the stock is 5.90 percent and its annual dividend per share was 1.66. It is important to note, however, that the 5.90% dividend yield ratio should be regarded as a guide only, as many other factors should be taken into consideration before making any investment decision.
